These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 34779161)

  • 1. [Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].
    Chen G; Wang Y; Ying X; Pang D; Liao L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1374-1379. PubMed ID: 34779161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Sacral Neuromodulation in Ambulatory Spina Bifida Patients with Neurogenic Bladder and Bowel Dysfunction.
    Chen G; Liao L; Deng H
    Urology; 2021 Jul; 153():345-350. PubMed ID: 33556449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic sacral neuromodulation for pelvic floor dysfunction in children with spina bifida].
    Dekopov AV; Tomskiy AA; Isagulyan ED; Yurasov IS; Salyukova YR; Salyukov RV
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(1):48-55. PubMed ID: 35170276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Video-urodynamics efficacy of sacral neuromodulation for neurogenic bladder guided by three-dimensional imaging CT and C-arm fluoroscopy: a single-center prospective study.
    Shan S; Zhu W; Zhang G; Zhang Q; Che Y; Wen J; Wang Q
    Sci Rep; 2022 Sep; 12(1):16306. PubMed ID: 36175471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Video-urodynamic effects of vibegron, a new selective β3-adrenoceptor agonist, on antimuscarinic-resistant neurogenic bladder dysfunction in patients with spina bifida.
    Aoki K; Momose H; Gotoh D; Morizawa Y; Hori S; Nakai Y; Miyake M; Anai S; Torimoto K; Tanaka N; Yoneda T; Matsumoto Y; Fujimoto K
    Int J Urol; 2022 Jan; 29(1):76-81. PubMed ID: 34608669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of bowel management on urodynamic findings in spina bifida children with detrusor overactivity and detrusor sphincter dyssynergia.
    Milivojevic S; Milic N; Lazovic JM; Radojicic Z
    J Pediatr Urol; 2020 Oct; 16(5):556.e1-556.e7. PubMed ID: 32376289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can ultrasound measurement of bladder wall thickness be a useful adjunct for regular urodynamics in children with spina bifida?
    Togo M; Kitta T; Chiba H; Ouchi M; Abe-Takahashi Y; Higuchi M; Kusakabe N; Shinohara N
    J Pediatr Urol; 2021 Oct; 17(5):734.e1-734.e8. PubMed ID: 34332835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk determination for upper urinary tract damage in children with neuropathic bladder.
    Ekberlİ G; Taner S
    J Paediatr Child Health; 2023 Jul; 59(7):863-870. PubMed ID: 36999336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: a 10-year experience.
    Choi EK; Hong CH; Kim MJ; Im YJ; Jung HJ; Han SW
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):798-803. PubMed ID: 23177928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The consequence after introduction of clean intermittent catheterization (CIC) in children with neurogenic bladder dysfunction secondary to spina bifida--the comparison of patients with and without upper urinary tract dilation at the time CIC was introduced].
    Obara K; Komeyama T; Mizusawa T; Tsutsui T; Wakatsuki H; Arai K; Kosegawa E; Suzuki K; Takahashi K
    Nihon Hinyokika Gakkai Zasshi; 2003 Nov; 94(7):664-70. PubMed ID: 14671996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the neurogenic bladder in spina bifida.
    de Jong TP; Chrzan R; Klijn AJ; Dik P
    Pediatr Nephrol; 2008 Jun; 23(6):889-96. PubMed ID: 18350321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of sacral neuromodulation on video-urodynamic parameters of neurogenic lower urinary tract dysfunction in a patient with vesicoureteral reflux: a case report.
    Meng L; Tian Z; Wang M; Liu X; Ma T; Wang J; Zhang W; Zhang Y
    Ann Palliat Med; 2022 Apr; 11(4):1568-1574. PubMed ID: 35523758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury.
    Redshaw JD; Lenherr SM; Elliott SP; Stoffel JT; Rosenbluth JP; Presson AP; Myers JB;
    BMC Urol; 2018 Aug; 18(1):72. PubMed ID: 30157824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mirabegron, a β3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study.
    Park JS; Lee YS; Lee CN; Kim SH; Kim SW; Han SW
    World J Urol; 2019 Aug; 37(8):1665-1670. PubMed ID: 30511212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for upper urinary tract deterioration in adult patients with spina bifida.
    Haudebert C; Hascoet J; Samson E; Jezequel M; Voiry C; Brochard C; Richard C; Kerdraon J; Siproudhis L; Manunta A; Peyronnet B
    World J Urol; 2023 Apr; 41(4):1187-1192. PubMed ID: 36808530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home bladder pressure measurements correlate with urodynamic storage pressures and high-grade hydronephrosis in children with spina bifida.
    Huen KH; Chamberlin JD; Macaraeg A; Davis-Dao CA; Williamson SH; Beqaj L; Abdelhalim A; Mahmoud R; Stephany HA; Chuang KW; Wehbi EJ; Khoury AE
    J Pediatr Urol; 2022 Aug; 18(4):503.e1-503.e7. PubMed ID: 35792042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
    Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
    Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sacral neuromodulation on bowel dysfunction in patients with neurogenic bladder.
    Chen G; Liao L; Wang Y; Ying X
    Colorectal Dis; 2020 Dec; 22(12):2155-2160. PubMed ID: 32681678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Sacral Neuromodulation by Converting Constant Frequency Stimulation Into Variable Frequency Stimulation in Patients With Detrusor Overactivity and Impaired Contractility: A Single-Center Prospective Study.
    Zhu W; Shan S; Zhang G; Zhang Q; Zhang J; Che Y; Wen J; Wang Q
    Neuromodulation; 2023 Dec; 26(8):1836-1844. PubMed ID: 35977853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.